Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival.
about
Large scale copy number variation (CNV) at 14q12 is associated with the presence of genomic abnormalities in neoplasiaThe Effect of Imatinib Mesylate for Newly Diagnosed Philadelphia Chromosome-Positive, Chronic-Phase Myeloid Leukemia in Sub-Saharan African Patients: The Experience of Côte d'Ivoire.Bone marrow pathology predicts mortality in chronic hemodialysis patientsMechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV.Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia.p53 causes butein‑mediated apoptosis of chronic myeloid leukemia cells.Re-emergence of interferon-α in the treatment of chronic myeloid leukemiaAbnormal integrin-mediated regulation of chronic myelogenous leukemia CD34+ cell proliferation: BCR/ABL up-regulates the cyclin-dependent kinase inhibitor, p27Kip, which is relocated to the cell cytoplasm and incapable of regulating cdk2 activityPrognostic and predictive implications of Sokal, Euro and EUTOS scores in chronic myeloid leukaemia in the imatinib era-experience from a tertiary oncology centre in Southern India.Selection of therapy: rational decisions based on molecular events.Prognostic Significance of Treatment Response in CML in View of Current Recommendations for Treatment and Monitoring.A Rare Monocytic Crisis of Chronic Myelogenous Leukemia Presenting with Unusual Extramedullary Manifestations and an Atypical (14;22)(q24;q11.2) Translocation in the Bone Marrow.
P2860
Q33245898-2CCB8B70-BD40-47F4-A043-1666379383A2Q34123610-2E605561-958F-4022-AEF9-BB14EA92A575Q35162482-3C9EBFF0-E9FC-42DF-A596-2FBDFB842487Q35606319-38FFAB35-B406-4F50-8AC7-B1124CF987A3Q35871366-87BFC241-2C0A-48D1-B590-1783D457B161Q36520233-76539174-A9D2-4B2D-92C5-9C9ACDB89B6AQ36989407-F43A2468-5AA5-4B1F-A2B9-34BDA1CDB399Q37251148-9D25844E-DFA6-482C-91E9-B6AC2433B1A0Q37404680-C85583F4-58F2-42D2-A990-3392CF8DE6D1Q37952910-2813120D-906F-445D-8670-CD06AED01476Q38095956-B6EC9839-989F-4F06-95FA-01D7C0A62966Q50095934-975370DF-B8E4-4749-8067-F55E9701E054
P2860
Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival.
description
1985 nî lūn-bûn
@nan
1985 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Chronic myelogenous leukemia: ...... ics and therapy with survival.
@ast
Chronic myelogenous leukemia: ...... ics and therapy with survival.
@en
type
label
Chronic myelogenous leukemia: ...... ics and therapy with survival.
@ast
Chronic myelogenous leukemia: ...... ics and therapy with survival.
@en
prefLabel
Chronic myelogenous leukemia: ...... ics and therapy with survival.
@ast
Chronic myelogenous leukemia: ...... ics and therapy with survival.
@en
P2093
P1433
P1476
Chronic myelogenous leukemia: ...... ics and therapy with survival.
@en
P2093
Freireich EJ
Kantarjian HM
Keating MJ
McCredie KB
Walters RS
P304
P407
P577
1985-12-01T00:00:00Z